Abstract
The focus of this article is on clinical ethics issues in the thyroid disease context. Clinical ethics is a subspecialty of bioethics that deals with bedside ethical dilemmas that specifically involve the provider-patient relationship. Such issues include consent and capacity; weighing therapeutic benefits against risks and side-effects; innovative therapies; end of life care; unintended versus intentional harms to patients or patient populations; and healthcare access. This article will review core ethical principles for practice, as well as the moral and legal requirements of informed consent. It will then discuss the range of unique and universal ethical issues and considerations that present in the management of autoimmune thyroid disease and thyroid cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 545-564 |
| Number of pages | 20 |
| Journal | Endocrinology and Metabolism Clinics of North America |
| Volume | 43 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adjuvant radioactive iodine therapy
- Autoimmune thyroid disease
- Clinical ethics
- Informed consent
- Radioablation
- Thyroid cancer
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology
Fingerprint
Dive into the research topics of 'Ethical issues in the management of thyroid disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver